Viking Global Investors

Founded in 1999, Viking Global Investors ("Viking") is a global firm with a fundamental, research-intensive, long-term-focused approach to investing. We currently manage over $49 billion in capital.

 

Viking’s private healthcare team:

  • Dedicated healthcare team with extensive scientific training and deep domain expertise in biotech, medtech, healthcare services and digital health
  • Close collaboration with Viking’s public market team, providing more than 20 years of public investment expertise and insight 
  • Focused on aligning with high-quality companies and best-in-class management teams and providing financial and advisory support to help maximize long-term value as businesses scale

 

Track record highlights:

  • $3.5B+ total capital invested in healthcare since inception
  • 70+ healthcare investments since inception
  • 100% Rate of IPO participation in our healthcare companies
  • $20-$500M+ target deployment per investment


Address

New York
New York
United States

Website

https://vikingglobal.com/

Contact Exhibitor


Loading
View all Partnering Companies

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS